Table 4C

Change in MacTSQ subscales between M1 (MacTSQ baseline) to M6, 12 and 18 in the subset of participants in whom at baseline the study eye was the ‘worse’ eye compared with the fellow eye in terms of BCVA letters

Change in MacTSQ subscalesMean 1Mean 2Difference95% CISignificance
Subscale 1: information provision and convenience
Pair 1 (n=69)
Months 1–6
32.8633.720.870.18 to 1.560.015
Pair 2 (n=70)
Subscale 1
Months 1–12
33.3134.200.890.29 to 1.480.004
Pair 3 (n=67)
Months 1–18
33.2434.040.810.08 to 1.540.031
Subscale 2: impact of treatment and treatment satisfaction
Pair 4 (n=70)
Months 1–6
28.8731.202.591.56 to 3.62<0.001
Pair 5 (n=70)
Months 1–12
29.5732.343.472.46 to 4.48<0.001
Pair 6 (n=67)
Months 1–18
28.7332.673.942.81 to 5.10<0.001
  • BCVA, best-corrected visual acuity; MacTSQ, Macular Disease Society Treatment Satisfaction Questionnaire.